Ahmad Mourad

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Thomas L Holland, Adit A. Ginde, Roger Paredes et al. · The Lancet Respiratory Medicine · 2022 · 124 citations · Full text

Covid-19 Pandemic, Antiviral Therapy, Clinical Trials +3

COVID-19-associated brief psychotic disorder

Colin M. Smith, Jonathan Komisar, Ahmad Mourad et al. · BMJ Case Reports · 2020 · 114 citations · Full text

Family Medicine, Psychiatric Disorders, Mental Health +16

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19: an international collaborative meta-analysis of randomized trials

Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud et al. · 2020 · 78 citations · Full text

Population Health Sciences, Pharmacotherapy, Covid-19 Epidemiology +21

Reduction in Expected Survival Associated With Nontuberculous Mycobacterial Pulmonary Disease

Ahmad Mourad, Arthur W. Baker, Jason E. Stout · Clinical Infectious Diseases · 2020 · 41 citations · Full text

Treatment of travellers' diarrhoea: zaldaride compared with loperamide and placebo.

G Silberschmidt, Mildred Schick, Robert Steffen et al. · PubMed · 1995 · 32 citations